ATM and breast cancer: Most of the ATM mutations occurring in A-T patients are frameshift or nonsense mutations leading to protein truncation or splice junction variants [6, 7] The role of A-T-causing mutations in cancer susceptibility (in particular breast cancer) is still debated and some studies have shown that a subset of rare, evolutionarily unlikely missense substitutions are important [15, 35, 36].